Introduction

A. Protein turnover
Protein turnover in muscle is a ratio of muscle protein accretion to protein degradation. Muscle cell protein accretion is commonly referred to as protein synthesis and can be greatly impacted in vitro by cell proliferation. A number of compounds, pharmaceutical agents, and drugs can be used to affect muscle turnover. Many of these protein-affecting compounds are tested for use in domestic livestock to enhance growth and marketability. Some procedures for measuring protein turnover include measuring N τ -methylhistidine excretion, infusion with [ 2 H 5 ]-phenylalanine, and feeding radioactively labeled amino acids to live animals [10, 11, 15] . Unfortunately these methods can be both expensive and labor intensive, therefore requiring only a few animals to be treated in a single experiment.
B. The myoblast model
Myoblasts are myogenic muscle cell precursors [4] . Cloned myoblast lines can be easily maintained and rapidly cultured allowing researchers to maintain a constant supply of muscle cells. A number of proteins found in adult muscle also have been shown to be expressed in myogenic myoblasts. Myoblasts have been shown to express myosin, actin, titin, nebulin, desmin, vimentin, and zeugmatin proteins [6, 8, 19] . Myoblasts are known to have a number of receptors that are found in adult muscle, such as steroid receptors like the 1,25-dihydroxyvitamin D 3 receptor [20] , androgen receptors [21] , estrogen receptors [4], glucocorticoid receptors [2] , and a number of β-adrenergic receptors [16, 18] . Thus, both myoblasts and myotubes have proven to be efficient in vitro models of in vivo adult muscle.
C. Application of pharmaceuticals to muscle cell C. cultures
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hormones or drugs may be pharmacological but not physiological, thus the effects may not represent the physiological response in vivo. An example of this is exceptionally high concentrations of pharmaceuticals used in toxicological studies, wherein, in some cases, the concentration far exceeds the capacity of animal detoxification systems, resulting in an artificial situation [16] . While measuring protein turnover in vitro by means of simply adding drugs to muscle cell culture media are fairly rapid and inexpensive, the above problems makes interpretation of these results difficult if not false.
D. A combined model of applying muscle extracts D. from treated animals to myoblasts
Pharmaceutical agents typically build up in tissues of the liver, kidney and in muscle [7] . To utilize this build-up of residues and intrinsic factors pharmakinetically affecting muscle, we have developed a method of determining overall treatment effects on protein synthesis and protein degradation. In this technique muscle extracts from treated animals are added to growth media and applied to myoblasts. Thus, muscle cells receive residues of the compound originally administered, major metabolites, and other compounds that are produced by the body in response to administration (e.g. insulin like growth factor). Because each pharmaceutical agent affecting protein turn-over functions uniquely, the methods below are meant to determine if a compound affects protein synthesis and/or protein degradation in livestock animals. Further studies will need to be conducted to determine exactly how each individual compound affects protein synthesis or degradation. 
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